WilmerHale Advises Linde on the Realignment of Its Joint Ventures in Asia

Download IconDownload Print IconPrint

WilmerHale Advises Linde on the Realignment of Its Joint Ventures in Asia

Client News

Related Solutions

WilmerHale Brussels has a collegial team culture geared to providing results in often-demanding proceedings. We have extensive experience in all areas of EU competition law, including mergers before the European Commission, worldwide merger control filings, cartel investigations (in Europe and worldwide), abuse of monopoly power, and State aid cases. We also regularly provide transactional advice, supporting joint ventures and distribution systems.

Our team has helped clients in some of the largest and most complex mergers of recent years, guiding them through EU merger control, including Phase 1 and Phase 2 cases with remedies, and other challenges requiring policy insight, legislative advocacy and government affairs experience. We have handled hundreds of procedures, ranging from cartel defense work to other alleged infringements and complaints. We have successfully represented third parties seeking to oppose mergers or challenge monopolies and exclusionary conduct, both through EC proceedings and litigation. We have assisted clients with State aid procedures.

 
We offer clients exceptional insight in dealing with competition agencies in the United States, Europe and around the world.

Technology company The Linde Group, and worldwide industry and medical gases company Air Liquide, signed agreements for the realignment of their joint ventures in Asia.

Following approval by the competent authorities, Linde will acquire the shares of Air Liquide in gas companies Malaysian Oxygen (Malaysia) and Hong Kong Oxygen & Acetylene (Hong Kong). In return, Linde will sell its shares in Singapore Oxygen (Singapore), Eastern Industrial Gases (Thailand), Vietnam Industrial Gases (Vietnam) and Brunei Oxygen (Brunei) to Air Liquide. Upon closing of these transactions, Linde will receive a net purchase price of EUR 275 million.

The realignment of the joint ventures follows from one of the conditions imposed by the European Commission for granting clearance of Linde's acquisition of The BOC Group plc.

WilmerHale regularly advises Linde on matters regarding competition law and merger control. In previous months, WilmerHale has advised and represented Linde on its acquisition of UK-based The BOC Group plc and US company Spectra Gases Inc., as well as the disposal of BOC Gazy Sp. z o.o. and KION GmbH.

In the realignment of its joint ventures with Air Liquide in Asia, Linde was advised on merger control issues by Berlin partner Ulrich Quack as well as by the associates Dr. Alexander Jüngling, Christian Wörz and Dr. Oliver Fleischmann from the Berlin office.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel